VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,855 | -61.8% | 198 | 0.0% | 0.00% | – |
| Q2 2023 | $4,857 | +22.8% | 198 | +16.5% | 0.00% | – |
| Q1 2023 | $3,956 | -100.0% | 170 | -100.0% | 0.00% | -100.0% |
| Q4 2022 | $27,825,662 | +695541.6% | 1,099,394 | +538818.6% | 0.14% | – |
| Q3 2022 | $4,000 | -100.0% | 204 | -100.0% | 0.00% | -100.0% |
| Q2 2022 | $19,979,000 | +285314.3% | 784,411 | +288286.4% | 0.15% | – |
| Q1 2022 | $7,000 | -50.0% | 272 | -19.8% | 0.00% | – |
| Q4 2021 | $14,000 | +75.0% | 339 | +86.3% | 0.00% | – |
| Q3 2021 | $8,000 | -11.1% | 182 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | -89.9% | 182 | -89.5% | 0.00% | -100.0% |
| Q1 2021 | $89,000 | -23.9% | 1,739 | -60.3% | 0.00% | 0.0% |
| Q4 2020 | $117,000 | +1850.0% | 4,378 | +2445.3% | 0.00% | – |
| Q3 2020 | $6,000 | +50.0% | 172 | +100.0% | 0.00% | – |
| Q2 2020 | $4,000 | – | 86 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |